Who
Mel Sorensen
President and CEO
Company insider
Files Form 4 as: President and CEO, Galera Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 1
- Sells
- 2
- Bought
- $168K
- Sold
- $6,091
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jan 2020
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —975 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —30,000 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —30,000 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —975 | filing |
| 20 Nov 2025filed 24 Nov 2025 | Galera TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,40070,000 at $0.02 | filing |
| 1 May 2025filed 5 May 2025 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000,000 at $0.00 | filing |
| 16 Aug 2024filed 20 Aug 2024 | Galera TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,69167,015 at $0.07 | filing |
| 10 Mar 2023filed 14 Mar 2023 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $168K100,000 at $1.68 | filing |
| 25 Feb 2023filed 28 Feb 2023 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —440,000 at $0.00 | filing |
| 28 Feb 2022filed 2 Mar 2022 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —264,400 at $0.00 | filing |
| 26 Mar 2021filed 30 Mar 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $182K170,075 at $1.07 | filing |
| 26 Mar 2021filed 30 Mar 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code M | $54K46,940 at $1.14 | filing |
| 26 Mar 2021filed 30 Mar 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —170,075 at $0.00 | filing |
| 26 Mar 2021filed 30 Mar 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —46,940 at $0.00 | filing |
| 26 Jan 2021filed 28 Jan 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 31 Jan 2020filed 4 Feb 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —186,087 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.